MW

Martin B. Wax

PA Panoptica: 5 patents #1 of 3Top 35%
AR Alcon Research: 3 patents #64 of 267Top 25%
AP Arrowhead Pharmaceuticals: 3 patents #53 of 121Top 45%
PH Pharmacia: 2 patents #167 of 528Top 35%
AR Arrowhead Research: 2 patents #3 of 49Top 7%
WU Washington University: 1 patents #704 of 1,596Top 45%
CU Columbia University: 1 patents #1,151 of 2,492Top 50%
AL Alcon: 1 patents #518 of 866Top 60%
📍 Westlake, TX: #3 of 16 inventorsTop 20%
🗺 Texas: #7,815 of 125,132 inventorsTop 7%
Overall (All Time): #255,093 of 4,157,543Top 7%
18
Patents All Time

Issued Patents All Time

Showing 1–18 of 18 patents

Patent #TitleCo-InventorsDate
10307404 Ocular formulations for drug-delivery to the posterior segment of the eye David P. Bingaman, Paul G. CHANEY 2019-06-04
10183014 Ocular formulations for drug-delivery and protection of the anterior segment of the eye David P. Bingaman, Paul G. CHANEY 2019-01-22
10092549 Ocular formulations for drug-delivery to the posterior segment of the eye David P. Bingaman, Paul G. CHANEY 2018-10-09
9814702 Ocular formulations for drug-delivery and protection of the anterior segment of the eye David P. Bingaman, Paul G. CHANEY 2017-11-14
9752147 RNAi-mediated inhibition of connexin 43 for treatment of IOP-related conditions Jon E. Chatterton, Abbot F. Clark 2017-09-05
9623011 Ocular formulations for drug-delivery and protection of the anterior segment of the eye David P. Bingaman, Paul G. CHANEY 2017-04-18
9476047 RNAi-mediated inhibition of connexin 43 for treatment of IOP-related conditions Jon E. Chatterton, Abbot F. Clark 2016-10-25
9446026 Ocular formulations for drug-delivery to the posterior segment of the eye David P. Bingaman, Paul G. CHANEY 2016-09-20
9422556 RNAi-related inhibition of TNF-alpha signaling pathway for treatment of ocular angiogenesis Jon E. Chatterton, Abbot F. Clark, David P. Bingaman, Adrian M. Timmers 2016-08-23
9173896 RNAi-mediated inhibition of connexin 43 for treatment of IOP-related conditions Jon E. Chatterton, Abbot F. Clark 2015-11-03
9139834 RNAi-related inhibition of TNF alpha signaling pathway for treatment of ocular angiogenesis Jon E. Chatterton, Abbot F. Clark, David P. Bingaman, Adrian M. Timmers 2015-09-22
8865670 RNAi-related inhibition of TNFα signaling pathway for treatment of glaucoma Jon E. Chatterton, Abbot F. Clark, David P. Bingaman, Adrian M. Timmers 2014-10-21
8754202 RNAi-related inhibition of TNFα signaling pathway for treatment of ocular angiogenesis Jon E. Chatterton, Abbot F. Clark, David P. Bingaman, Adrian M. Timmers 2014-06-17
8632809 Water insoluble polymer matrix for drug delivery Bahram Asgharian, Masood A. Chowhan 2014-01-21
7592324 RNAi-mediated inhibition of ocular targets Allan R. Shepard, Jon E. Chatterton, Abbot F. Clark 2009-09-22
6814966 Methods for treating glaucoma Gulgun Tezel 2004-11-09
6531128 Methods for treating glaucoma Gulgun Tezel 2003-03-11
5545626 Method of treating glaucoma with oligonucleotides Cy Stein 1996-08-13